Belite Bio uplisting to Nasdaq Global Select Market signals increased market visibility.
Context
What happened: Belite Bio (BLTE) received Nasdaq approval to transfer its listing from the Nasdaq Capital Market to the Nasdaq Global Select Market.
Key numbers: Trading on the Nasdaq Global Select Market begins at market open on October 19, 2026.
Why it matters: The content does not state any consequence or significance beyond the listing transfer itself.